Scailyte Announces Jan Lichtenberg, CEO at inSphero, as a Member of the Board of Directors
BASEL, SWITZERLAND / ACCESSWIRE / May 9, 2023 / Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is proud to announce the...
Scailyte Announces Collaboration With Turnstone Biologics to Identify Biomarker Signatures in Solid Tumors With TIL Therapy
Scailyte AG, an ETH Zürich spin-off with a proprietary analytical sequencing, and data analysis platform to draw insights into complex disease patterns from single-cell data,...